Bookmark and Share

John A. Olson Jr.
 

John A. Olson Jr. M.D., Ph.D.

Academic Title: Professor
Primary Appointment: Surgery
Secondary Appointments: Biochemistry and Molecular Biology, Otorhinolaryngology-Head & Neck Surgery
Administrative Title: Associate Director Of The University Of Maryland Marlene And Stewart Greenebaum Cancer Center (U.M.G.C.C.), Division Head, General And Oncologic Surgery
Additional Title(s): Campbell & Jeanette Plugge Professor and Vice Chair of the Department of Surgery
jolson@smail.umaryland.edu
Location: UMMC N4E40
Phone: 410-328-6187
 

Personal History:

Dr. John Olson is the Campbell & Jeanette Plugge Professor and Vice Chair of Surgery at the University of Maryland School Of Medicine. Dr. Olson specializes in endocrine and oncologic surgery with a focus on surgical diseases of the thyroid, parathyroid, adrenal glands, and breast. Dr. Olson is a member-elect of the American Surgical Association, and is a member of the Halsted Society, the Society of Clinical Surgeons, the Society of University Surgeons, and the Southern Surgical Association. He has been named to America's Top Doctors, Best Doctors, and US News and World Report's top 1% of doctors in his specialty in the United States.

Prior to coming to University of Maryland, Dr. Olson was Chief of the Section of Endocrine, Breast and Oncologic Surgery at Duke University Medical Center.

Dr. Olson received his Medical and Doctor of Philosophy Degrees from the University of Florida College of Medicine. He completed a residency in General Surgery at Barnes Jewish Hospital in St. Louis, and a fellowship in Surgical Oncology at Memorial Sloan Kettering Cancer Center.

Dr. Olson’s approach to understanding and developing treatment for parathyroid tumors is characterized by the integration of clinical and laboratory research using advanced analytic techniques. His efforts to investigate the molecular pathogenesis of parathyroid tumors have been funded by the National Institutes of Health. Dr. Olson also has been co-principle investigator of clinical trials that documented the ability of aromatase inhibitors to improve surgical outcomes for women with breast cancer. His clinical research also includes genetic determinants of breast cancer clinical outcomes.